{"result": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that provides comprehensive information on internal medicine, including adrenal disorders.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>ORGANIZATION<|>The European Society of Endocrinology is a professional organization that provides guidelines for the management of adrenal incidentalomas.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides evidence-based information on various medical topics, including adrenal incidentalomas.)\n##\n(\"entity\"<|>ADRENAL INCIDENTALOMA<|>EVENT<|>Adrenal incidentaloma refers to an adrenal mass that is discovered incidentally during imaging studies performed for other reasons.)\n##\n(\"entity\"<|>MÉXICO DF<|>GEO<|>Mexico City, known as México DF, is the capital of Mexico and the location where the Harrison textbook was published.)\n##\n(\"entity\"<|>DHEA-S<|>PERSON<|>DHEA-S is a hormone that may be requested in the study of adrenal incidentalomas, though its role is controversial.)\n##\n(\"entity\"<|>17-HIDROXIPROGESTERONA<|>PERSON<|>17-Hidroxiprogesterona is a hormone that should be measured in cases of bilateral adrenal incidentalomas to rule out congenital adrenal hyperplasia due to 21-hydroxylase deficiency.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>The European Society of Endocrinology provides guidelines referenced in the Harrison textbook for managing adrenal incidentalomas<|>7)\n##\n(\"relationship\"<|>UPTODATE<|>ADRENAL INCIDENTALOMA<|>UpToDate provides information and guidelines regarding the management and understanding of adrenal incidentalomas<|>8)\n##\n(\"relationship\"<|>ADRENAL INCIDENTALOMA<|>17-HIDROXIPROGESTERONA<|>17-Hidroxiprogesterona is a hormone that is relevant in the evaluation of adrenal incidentalomas<|>6)\n##\n(\"relationship\"<|>ADRENAL INCIDENTALOMA<|>DHEA-S<|>DHEA-S is a hormone that may be involved in the assessment of adrenal incidentalomas<|>6)\n##\n(\"relationship\"<|>MÉXICO DF<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Harrison Principios de Medicina Interna was published in México DF<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: debe realizarse a primera hora                  la determinación del cociente ALD/ARP serían las pruebas básicas en el estudio funcional\n         de la mañana, con el paciente sentado. No precisa la retirada de la medicación antihiper-                                           del incidentaloma suprarrenal.\n         tensiva, con algunas salvedades.                Los antagonistas de la aldosterona (espironolactona y                               La supresión con dexametasona es la prueba de elección para valorar la posibilidad de se-\n         eplerenona) deben ser retirados 6 semanas antes para poder hacer una interpretación                                                 creción autónoma de cortisol. Si la intención es detectar el máximo de pacientes a expen-\n         correcta, excepto cuando persiste la hipopotasemia a pesar del tratamiento, lo que in-                                              sas de falsos       positivos, se debería escoger el punto de corte de 1,8 µg/dl. De esta manera,\n         dica que el receptor de aldosterona está completamente bloqueado y la actividad de reni-                                            podríamos asumir que              un valor de cortisol inferior a 1,8 µg/dl excluye la presencia de\n         na plasmática sí que podría suprimirse en el paciente con hiperaldosteronismo primario,                                             hipercortisolismo. Si la intención es intentar evitar al máximo los falsos positivos, debería\n         siendo esta la única en la que el ratio ALD/ARP sería útil. Otros diuréticos ahorradores de                                         escogerse un valor de corte de 5 µg/dl. Algunas guías clasifican a los sujetos con valores\n         potasio,    amilorida o      triamtereno no        interfieren, a menos que            se utilicen en dosis        elevadas.        entre 1,8 y 5      µg/dl como frenación intermedia.\n         Los fármacos inhibidores de la enzima convertidora de angiotensina (IECA) y los antago-                                             La solicitud de DHEA-S en el estudio del incidentaloma suprarrenal es controvertida. Al-\n         nistas del receptor         de angiotensina        II (ARA-II) aumentan          el valor de la ARP        y disminuyen el          gunos estudios sugieren que puede ser un marcador, aunque con más especificidad que\n         ratio, dando lugar a posibles falsos negativos, por lo que no sería interpretable un resultado                                      sensibilidad, de malignidad. El resto de hormonas sexuales deberían solicitarse en caso\n         normal. Sin embargo, una actividad de renina plasmática suprimida en un paciente en                                                 de clínica sugestiva o ante la sospecha de carcinoma suprarrenal, ya que es muy rara la\n         tratamiento con IECA/ARA-II es muy sugerente de hiperaldosteronismo primario.                                                       secreción de hormonas sexuales por un adenoma benigno.\n         Referencias:                                                                                                                        La determinación de 17-hidroxiprogesterona debería ser realizada en caso de incidenta-\n         • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison\n           Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.                               loma suprarrenal         bilateral para descartar una hiperplasia suprarrenal                       congénita por       déficit\n         • Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentaloma: European Society   de 21-hidroxilasa.\n           of Endocrinology Clinical Practice. Guideline in collaboration with the European Network for the Study of adrenal tumors.\n           Eur J Endocrinol. 2016; 75:G1-G34.                                                                                                El seguimiento          del  incidentaloma suprarrenal no                  está   muy bien        definido, pero parece\n         • Recasens Sala M. Incidentaloma adrenal. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es\n           (última modificación: 25 de noviembre de 2015).                                                                                   prudente hacer un estudio              anual hormonal, al menos, durante 4 años.\n         • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n           of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.                                                              Referencias:\n         • Young WF, Jr, Kebebew E. The adrenal incidentaloma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com.                • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison\n           Literature review current through: Apr. 2019.                                                                                       Principios de Medicina Interna. 19.ª edición en español. México DF: Mc\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}